Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Condition:   Hepatocellular Carcinoma Interventions:   Drug: Regorafenib;   Drug: Nivolumab Sponsors:   Fundacion Clinic per a la Recerca Biomédica;   Apices Soluciones S.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials